ArticleCancers2020

Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence.

Kamal Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.